RecruitingNot ApplicableNCT06657833

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Sponsor

Fundación EPIC

Enrollment

128 participants

Start Date

Dec 17, 2024

Study Type

INTERVENTIONAL

Conditions

Coronary Artery Disease

Summary

International, investigator-driven, multicenter, open-label, prospective randomized controlled trial where patients with de novo lesions due to calcified nodules (CN) were randomized to drug eluting balloon (DEB) or drug eluting stents (DES).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloon and a medical device called Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting stent for people with coronary artery disease. The study is currently recruiting participants at 13 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPercutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloon

Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloon

DEVICEPercutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting stent

Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting stent

Locations(13)

Hospital Del Mar

Barcelona, Spain

Hospital Universitario de La Paz

Fuencarral-El Pardo, Spain

Hospital Universitario de Galdakao-Usansolo

Galdakao, Spain

Hospital Universitario de León

León, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital Universitario Puerta de Hierro

Madrid, Spain

Hospital Clínico San Carlos

Moncloa-Aravaca, Spain

Hospital Universitario de Navarra

Pamplona, Spain

Hospital General Universitario de Valencia

Valencia, Spain

Hospital Universitario y Politécnico La Fe

Valencia, Spain

Hospital Clínico Universitario de Valladolid

Valladolid, Spain

Hospital Universitario de Vigo

Vigo, Spain

Hospital Universitario Miguel Servet

Zaragoza, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06657833

Related Trials

Digital Long-term Follow-up of Patients With Coronary Artery Disease

NCT077203492 locations

Gangwon PCI Prospective Registry

NCT020381273 locations

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT0719069018 locations

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT072582902 locations

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT0677963023 locations